AVR anteris technologies global corp.

6.09%

$6.27

Cardiology, page-36

First 36 Last

Share
Profile

Follow
sewell64

5,336 Posts.

309

03/12/22

11:45

Post #: 65132212
Share

Originally posted by platinumstandard: ↑

Funny post. I remember you from your previous controversial posts. 1st fo all, does your cardiologist do TAVI? now cardiology is very very diversified and there is a lot of sub specialisations happening in the field. S/He may not even do TAVI and maybe a general non interventional cardiology and TAVI would not influence heavily his area of interest.

Secondly DUAVR is currently not in the market and unless your regional cardiologist has a specific interest in TAVI and been to the recent Boston and London meetings and attended all the sessions, it is not surprising that he has not heard about the product.

You may also noticed that Anteris have targeted the high volume TAVI cardiologists and being a regional centre of 200k people, chances are the hospital probably would even be doing TAVI.

I have recently spoken extensively to an interventional cardiologist who does mostly Medtronic TAVI , well 6months ago, before I brought DUAVR to his attention, he was not aware of the product, so there is nothing unusual about a regional cardiologist not knowing about AVR. However after he was briefed on the product, I ask the cardiologist to give me his honest opinion ,warts and all. His conclusion is the greatest risk for AVR now is for it to be acquired early and cheaply. BTW, I spoke to him not as a patient/clinician but more socially as I know him personally.

Expand

My cardiologist is not a cardiac surgeon and I don't think, but not sure, if he does catheter replacements. We have a large Cardiac Unit at our hospital and TAVR and SAVR are performed routinely. Thanks for your sensible, polite and non judgemental post.

Last edited by sewell64: 03/12/22

AVR Price at posting: $24.42 Sentiment: None Disclosure: Not Held
1 Upvote

0 Great analysis

Reply

Top Stories

RMX

Red Mountain: Chip samples point to 'large orogenic antimony mineral system' at Oaky Creek

Listen: HotCopper Wire Podcast 015 – Yeah, we're thinking the IPO market is back

AII

NATO’s 5% target: Why Almonty Industries’ mega mine and NASDAQ listing are a perfect fit for investors

BPH

Australia’s gas crisis is here – and dying coal plants aren’t helping

OCC

Orthocell sees 4% jump as Remplir used in first US surgery. But is that low?

Week 26 Wrap: Renewable gas fantasies; RBA July cut hope builds; copper's August peak?

MVF

Monash IVF shares cater 25% – Disaster or deep-value play?

HotCopper Highlights Week 26: Droneshield 2.0; Trigg re-jig & Virgin

PAR

Paradigm Biopharmaceuticals makes key acquisition moving into FY26

SRL

Sunrise pops on top scandium hits NSW explorer will now use for 'multi-decade' plan

First 36 Last

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

(20min delay)
Last $6.27		Change 0.360(6.09%)		Mkt cap ! $97.17M

Open	High	Low	Value	Volume
$5.93	$6.30	$5.91	$107.9K	17.39K

Buyers (Bids)

No.	Vol.	Price($)
1	3500	$6.12

Sellers (Offers)

Price($)	Vol.	No.
$6.27	200	1

View Market Depth

No.	Vol.	Price($)
1	3500	6.120
1	2000	6.100
1	1250	5.950
1	857	5.830
1	900	5.780

Price($)	Vol.	No.
6.300	463	1
6.400	130	1
6.500	255	1
6.550	1092	1
6.600	320	1

Last trade - 15.42pm 27/06/2025 (20 minute delay)

AVR (ASX) Chart

Cardiology, page-36

Red Mountain: Chip samples point to 'large orogenic antimony mineral system' at Oaky Creek

Listen: HotCopper Wire Podcast 015 – Yeah, we're thinking the IPO market is back

NATO’s 5% target: Why Almonty Industries’ mega mine and NASDAQ listing are a perfect fit for investors

Australia’s gas crisis is here – and dying coal plants aren’t helping

Orthocell sees 4% jump as Remplir used in first US surgery. But is that low?

Week 26 Wrap: Renewable gas fantasies; RBA July cut hope builds; copper's August peak?

Monash IVF shares cater 25% – Disaster or deep-value play?

HotCopper Highlights Week 26: Droneshield 2.0; Trigg re-jig & Virgin

Paradigm Biopharmaceuticals makes key acquisition moving into FY26

Sunrise pops on top scandium hits NSW explorer will now use for 'multi-decade' plan

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

Cardiology, page-36

Top Stories

Red Mountain: Chip samples point to 'large orogenic antimony mineral system' at Oaky Creek

Listen: HotCopper Wire Podcast 015 – Yeah, we're thinking the IPO market is back

NATO’s 5% target: Why Almonty Industries’ mega mine and NASDAQ listing are a perfect fit for investors

Australia’s gas crisis is here – and dying coal plants aren’t helping

Orthocell sees 4% jump as Remplir used in first US surgery. But is that low?

Week 26 Wrap: Renewable gas fantasies; RBA July cut hope builds; copper's August peak?

Monash IVF shares cater 25% – Disaster or deep-value play?

HotCopper Highlights Week 26: Droneshield 2.0; Trigg re-jig & Virgin

Paradigm Biopharmaceuticals makes key acquisition moving into FY26

Sunrise pops on top scandium hits NSW explorer will now use for 'multi-decade' plan

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News